Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,

Slides:



Advertisements
Similar presentations
Sperm macrocephaly syndrome in a patient without AURKC mutations and with a history of recurrent miscarriage Emanuela Molinari, Marzia Mirabelli, Stefania.
Advertisements

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Programmes and prospects for ovotechnology
Kay Neumann, Georg Griesinger  Reproductive BioMedicine Online 
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Diet and endometriosis risk: A literature review
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles  Scott J. Morin, Ashley W. Tiegs, Jason M.
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
HP-HMG versus rFSH in treatments combining fresh and frozen IVF cycles: success rates and economic evaluation  Jaro Wex-Wechowski, Ahmed M. Abou-Setta,
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response  William L. Ledger, Bart C.J.M. Fauser, Paul.
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF  Bart C.J.M. Fauser, Michael.
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study 
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
L. L. van Loendersloot, M. van Wely, S. Repping, F. van der Veen, P. M
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation  Hermann M. Behre, Colin.
Publication productivity in IVF in Europe, 1990–2006
Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective.
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Why are reproductive cancers more common in nulliparous women?
K. Gersak, A. Veble  Reproductive BioMedicine Online 
What’s on the mind of IVF consumers?
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis  Georg Griesinger, Robert Boostanfar, Keith.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa  F. Olivennes, G. Trew,
Cross-border reproductive care: a review of the literature
Influence of paternal age on ongoing pregnancy rate at eight weeks' gestation in assisted reproduction  Aukje Marieke Meijerink, Liliana Ramos, Kathrin.
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
Ronit Machtinger, Raoul Orvieto  Reproductive BioMedicine Online 
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Michael J. Levy, William Ledger, Efstratios M. Kolibianakis, Pieta C
Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles  Sotirios H. Saravelos,
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
Russell–Silver syndrome due to paternal H19/IGF2 hypomethylation in a patient conceived using intracytoplasmic sperm injection  M. Chopra, D.J. Amor,
Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management – meta-analyses  Daniele Santi, Giorgia.
Does ovarian stimulation regimen affect IVF outcome
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Ovarian stimulation and endometriosis progression or recurrence: a systematic review  Edgardo Somigliana, Paola Viganò, Laura Benaglia, Andrea Busnelli,
Pietro Gambadauro, Ramesan Navaratnarajah 
Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance  Shimon Segal,
The effect of protein supplement concentration in embryo transfer medium on clinical outcome of IVF/ICSI cycles: a prospective, randomized clinical trial 
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF  Jeroen van Disseldorp, Lude Franke, Rene.
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility  C.M. Howles, V. Alam, D. Tredway, R. Homburg,
Propofol versus thiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlled trial  Evangelia Goutziomitrou, Christos A. Venetis,
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome  Yavuz Emre Şükür,
Programmes and prospects for ovotechnology
Claudio Manna, Loris Nanni, Alessandra Lumini, Sebastiana Pappalardo 
John Yovich, James Stanger, Peter Hinchliffe 
Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study  Georg Griesinger, Henriette.
Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial  Ernesto Bosch, Jon Havelock, Fernando Sánchez.
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Fertility in cancer patients after cryopreservation of one ovary
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis, Georg Griesinger, Arthur Leader, Luk Rombauts, Pieta C. IJzerman-Boon, Bernadette M.J.L. Mannaerts  Reproductive BioMedicine Online  Volume 24, Issue 4, Pages 410-419 (April 2012) DOI: 10.1016/j.rbmo.2012.01.005 Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or recombinant FSH (rFSH). Data from (A) Engage and Ensure (pooled) and (B) Trust. Reproductive BioMedicine Online 2012 24, 410-419DOI: (10.1016/j.rbmo.2012.01.005) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Receiver operating characteristic curve for logistic regression model. The area under the curve is 0.753, showing the sensitivity of the final logistic regression model. Reproductive BioMedicine Online 2012 24, 410-419DOI: (10.1016/j.rbmo.2012.01.005) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.